Access DX and Individuals Settle US Genetic-Testing Kickback Allegations for $36.4 Million
Report date: (original source date). Article publication date: .
Report an error or privacy concernSummary
The US Department of Justice said Access DX Laboratory, former CEO Michael Stewart and businessman Harold Shatz agreed to pay a combined $36.4 million to resolve False Claims Act allegations. The United States alleged that, between January 2018 and January 2020, they paid marketers for patient referrals, paid telemedicine providers for doctors’ orders, unbundled billing codes and submitted claims for medically unnecessary genetic testing.
Stewart and Shatz separately agreed to plead guilty to conspiracy charges involving healthcare kickbacks and defrauding the United States; the source does not state that either has been convicted. Access DX also entered a five-year Corporate Integrity Agreement requiring compliance measures, audits, training and review of referral-source arrangements. The settlement includes a $7.2 million whistleblower share.